133 related articles for article (PubMed ID: 6482001)
41. [Immunological studies in a case of congenital nephrotic syndrome with focal extracapillary proliferative glomerulonephritis (author's transl)].
Winterleitner H; Eibl M; Krepler P
Klin Padiatr; 1977 Jul; 189(4):227-38. PubMed ID: 302366
[TBL] [Abstract][Full Text] [Related]
42. The role of complement in glomerulonephritis.
Simpson IJ
Aust N Z J Med; 1981; 11(Suppl 1):101-3. PubMed ID: 6942797
[No Abstract] [Full Text] [Related]
43. Effects of decomplementation on mercuric chloride-induced glomerulonephritis in Brown-Norway rats.
Capron M; Bascou C; Vial MC; Grossetete J; Hinglais N; Girard JF; Druet P
Clin Exp Immunol; 1982 Sep; 49(3):611-7. PubMed ID: 6216993
[TBL] [Abstract][Full Text] [Related]
44. Monoclonal IgG cryoglobulinemia with secondary development of glomerulonephritis and nephrotic syndrome.
Bengtsson U; Larsson O; Lindstedt G; Svalander C
Q J Med; 1975 Jul; 44(175):491-503. PubMed ID: 1178819
[TBL] [Abstract][Full Text] [Related]
45. [Recurrent post-infectious immune complex glomerulonephritis with persistent activation of the alternative complement pathway].
Arslan-Kirchner M; Ehrich JH; Kirschfink M; Helmchen U; Brodehl J
Monatsschr Kinderheilkd; 1990 Feb; 138(2):81-4. PubMed ID: 2138710
[TBL] [Abstract][Full Text] [Related]
46. [Determination of immune complexes in glomerular nephropathy].
Gluhovschi G; Mănescu N; Fernolendt M; Klinda C; Schultz C; Zosin C
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(5):473-80. PubMed ID: 6113666
[No Abstract] [Full Text] [Related]
47. [Immunopathological studies on pathogenesis of acute glomerulonephritis].
Hatano M
Nihon Rinsho; 1984 Jun; 42(6):1284-91. PubMed ID: 6481989
[No Abstract] [Full Text] [Related]
48. Alterations of complement components in disease.
Luskin AT; Tobin MC
Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862
[No Abstract] [Full Text] [Related]
49. [Plasma concentrations of complement components C3, C4, and C3PA in juvenile nephropathies].
Brai M; Amato G; Ziino M; Tolone G
G Batteriol Virol Immunol; 1975; 68(1-6):42-9. PubMed ID: 1205034
[TBL] [Abstract][Full Text] [Related]
50. [Activation of the complement system in different forms of glomerulonephritis].
Wegmüller E; Frey B; Hodler J
Schweiz Med Wochenschr; 1977 Jul; 107(29):1028-34. PubMed ID: 331469
[TBL] [Abstract][Full Text] [Related]
51. Idiopathic immune complex glomerulonephritis in dogs with multisystem involvement.
Jeraj KP; Vernier RL; Polzin D; Klausner JK; Osborne CA; Stevens JB; Michael AF
Am J Vet Res; 1984 Sep; 45(9):1699-705. PubMed ID: 6238560
[TBL] [Abstract][Full Text] [Related]
52. Increased serum and urinary neopterin in nephrotic syndrome indicate cell-mediated immune dysfunction.
Oda K; Arai T; Nagase M
Am J Kidney Dis; 1999 Oct; 34(4):611-7. PubMed ID: 10516339
[TBL] [Abstract][Full Text] [Related]
53. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
54. [Immunological studies of the mechanism of the therapeutic action of azathioprine and of indomethacin in chronic active glomerulonephritis and the nephrotic syndrome].
Campanacci L; Castellani A; Gambari PF; Huber W; Fagiolo U; Vesco F; Contini MG; Rebecca L
Minerva Nefrol; 1970; 17(4):127-50. PubMed ID: 4102147
[No Abstract] [Full Text] [Related]
55. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
[No Abstract] [Full Text] [Related]
56. [Progress in the knowledge of complement. II. Nephritic factors].
Leibowitch J; Lesavre P
Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
[No Abstract] [Full Text] [Related]
57. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation.
Mitchell DA; Taylor PR; Cook HT; Moss J; Bygrave AE; Walport MJ; Botto M
J Immunol; 1999 May; 162(10):5676-9. PubMed ID: 10229798
[TBL] [Abstract][Full Text] [Related]
58. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
Berthoux FC; Freyria AM
Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
[TBL] [Abstract][Full Text] [Related]
59. [Hypothesis on the basic immune disorders, the originating cause and the development of glomerulonephritis].
Belovezhdov N
Vutr Boles; 1984; 23(3):39-48. PubMed ID: 6464431
[TBL] [Abstract][Full Text] [Related]
60. C3 and C4 complements in glomerular disorders in children.
Alatas H; Wila Wirya IG; Tambunan T
Paediatr Indones; 1978; 18(3-4):. PubMed ID: 652371
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
